Table 1.
Baseline clinical status.
| Scale and score | PP population |
ITT population (n = 163) | |
|---|---|---|---|
| Yes (n = 124) | No (n = 39) | ||
| WFNS (ruptured only) – n (%) | |||
| Missing | 3 | 1 | 4 |
| I | 11 (25) | 5 (33.3) | 16 (27.1) |
| II | 16 (36.4) | 4 (26.7) | 20 (33.9) |
| III | 10 (22.7) | 0 | 10 (16.9) |
| IV | 1 (2.3) | 4 (26.7) | 5 (8.5) |
| V | 6 (13.6) | 2 (13.3) | 8 (13.6) |
| mRS – n (%) | |||
| Missing | 3 | 2 | 5 |
| 0 | 60 (49.6) | 21 (56.8) | 81 (51.3) |
| 1 | 31 (25.6) | 9 (24.3) | 40 (25.3) |
| 2 | 11 (9.1) | 1 (2.7) | 12 (7.6) |
| 3 | 10 (8.3) | 1 (2.7) | 11 (7) |
| 4 | 14 | 5.0 | 3 (1.9) |
| 5 | 8 (6.6) | 3 (8.1) | 11 (7) |
| 6 | 0 | 0 | 0 |
Baseline neurological status was evaluated by two of the World Federation Neurological Surgeons (WFNS) and the modified Rankin Scale (mRS) for per-protocol (PP) population and intention-to-treat (ITT) population.